Abbisko Cayman LimitedHKEX: 2256

Next Day Disclosure Returns

Oct 6, 2026 at 7:16 AM EDT · Issued by Abbisko Cayman Limited via HKEXnews

Filed with HKEX · Stock code 2256 · Oct 6, 2026 at 7:16 AM EDT · 7 pages · English

On 6ix: 6ix.com/news/next-day-disclosure-returns-45

Abbisko Cayman Limited on 6ix

Earlier from Abbisko Cayman

Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026Oct 2
2026 Interim reportSep 22
Voluntary announcement - abbisko therapeutics announces positive preliminary phase II results with lavengratinib (ABSK061) for the treatment of achondroplasiaSep 21
Poll results of the extraordinary general meeting held on September 17, 2026Sep 17
AACR 2026 | Abbisko Therapeutics Showcases Six Research Advances Highlighting pan-KRAS, 4th Generation EGFR, and Synthetic Lethality ApproachesApr 22

Later from Abbisko Cayman

Voluntary announcement - abbisko therapeutics' lavengratinib (ABSK061) for the treatment of achondroplasia granted orphan designation by emaOct 21

All Abbisko Cayman news releases

Follow Abbisko Cayman into a list and get an email when it puts out news.

Follow Abbisko Cayman